Chirospecific and subtype selective dopamine receptor binding of heterocyclic methoxynaphthamide analogs

Archiv der Pharmazie

Volumn 338, Issue 5-6, 2005, Pages 276-280

  Bettinetti, Laura ^a   Hübner, Harald ^a   Gmeiner, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Dopamine; Medicinal chemistry; Receptor

Indexed keywords

AMIDE; BP 897; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; FAUC 182; HETEROCYCLIC AMINE; LIGAND; METHOXYNAPHTHAMIDE DERIVATIVE; N (1 BENZYLPYRROLIDIN 3 YL)PYRAZOLO[1,5 A]PYRIDINE 3 CARBOXAMIDE; NAFADOTRIDE; PYRAZOLO[1,5 A]PYRIDINE 3 CARBOXAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; DOPAMINE RELEASE; DRUG STRUCTURE; MITOGENESIS; NONHUMAN; OPTICS; PRIORITY JOURNAL; RECEPTOR BINDING; SEXUAL DYSFUNCTION; STEREOISOMERISM; STEREOSPECIFICITY; SUBSTITUTION REACTION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BINDING SITES; CHO CELLS; CRICETINAE; HETEROCYCLIC COMPOUNDS; HUMANS; MUTAGENICITY TESTS; NAPHTHALENES; PYRAZOLES; PYRROLIDINES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; RECEPTORS, DOPAMINE; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SPIPERONE; STEREOISOMERISM; SULPIRIDE; SWINE; THYMIDINE; TRITIUM;

EID: 21844439491     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200400997     Document Type: Article

References (25)

1. S. Iwanami, M. Takashima, Y. Hirata, O. Hasegawa, S. Usuda, J. Med. Chem. 1981, 24, 1224-1230.
2. R. K. Mishra, S. Chiu, P. Chiu, C. P. Mishra, Methods Find. Exp. Clin. Pharmacol. 1983, 5, 203-233.
3. P. Sokoloff, J.-C. Schwartz, Trends Pharmacol. Sci. 1995, 16, 270-275.
4. J. Einsiedel, K. Weber, C. Thomas, T. Lehmann, H. Hübner, P. Gmeiner, Bioorg. Med. Chem. Lett. 2003, 13, 3293-3296.
5. a) A. E. Hackling, H. Stark ChemBioChem 2002, 3, 946-931;
6. b) J. N. Joyce, Pharmacol. Therap. 2001, 90, 231-259;
7. R. R. Luedtke, R. H. Mach, Curr. Pharm. Des. 2003, 9, 643-671.
8. a) A. H. C. Wong, H. H. M. Van Tol, Prog. Neuropsychopharmacol. Biol. Psych. 2003, 27, 1091-1099;
9. b) C. J. Price, Q. J. Pittman, J. Neurophysiol. 2001, 86, 1149-1155.
10. L. Bettinetti, K. Schlotter, H. Hübner, P. Gmeiner, J. Med. Chem. 2002, 45, 4594-4597.
11. F. Böckler, A. Leng, A. Mura, L. Bettinetti, J. Feldon, P. Gmeiner, B. Ferger, Biochem. Pharmacol. 2003, 66, 1025-1032.
12. R. Huisgen, R. Grashey, R. Krischke, Tetrahedron Lett. 1962, 3, 387-391.
13. P. Gmeiner, J. Sommer, Arch. Pharm. (Weinheim) 1988, 321, 505-507.
14. P. L. Anderson, J. P. Hasak, A. D. Kahle, N. A. Poalella, M. J. Shapiro, J. Heterocycl. Chem. 1981, 18, 1149-1152.
15. S. Löber, H. Hübner, W. Utz, P. Gmeiner, J. Med Chem. 2001, 44, 4691-2694.
16. C. Thomas, F. Orecher, P. Gmeiner, Synthesis 1998, 1491-1496.
17. G. Hayes, T. J. Biden, L. A. Selbie, J. Shine, Mol. Endocrinol. 1992, 6, 920-926.
18. P. Sokoloff, M. Andrieux, R. Besançon, C. Pilon, M.-P. Martres, B. Giros, J.-C. Schwartz, Eur. J. Pharmacol. 1992, 225, 331-337.
19. V. Asghari, S. Sanyal, S. Buchwaldt, A. Paterson, V. Jovanovic, H. H. M. Van Tol, J. Neurochem. 1995, 65, 1157-1165.
20. H. Hübner, C. Haubmann, W. Utz, P. Gmeiner, J. Med. Chem. 2000, 43, 756-762.
21. H. Hübner, J. Kraxner, P. Gmeiner, J. Med. Chem. 2000, 43, 4563-4569.
22. J. D. Brioni, R. B. Moreland, M. Cowart, G. C. Hsieh, A. O. Stewart, P. Hedlund, D. L. Donnelly-Roberts, M. Nakane, J. J. Lynch III, T. Kolasa, J. S. Polakowski, M. A. Osinski, K. Marsh, K. E. Andersson, J. P. Sullivan, Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 6758-63.
23. M. T. Rispens, O. J. Gelling, A. H. M. de Vries, A. Meetsma, F. van Bolhuis, B. L. Feringa, Tetrahedron 1996, 52, 3521-3546.
24. Y. N. Belokon, V. I. Maleev, S. O. Videnskaya, M. B. Saporovskaya, V. A. Tsyryapkin, V. M. Belikov, Bull. Acad. Sci. USSR Div. Chem. Sci. (EN), 1991, 40, 110-118.
25. Y. C. Cheng, W. H. Prusoff, Biochem. Pharmacol. 1973, 22, 3099-3108.